CARM1 and cancer: CARM1 is thought to contribute to cancer progression mainly through its coactivator activity targeting a plethora of transcription factors, such as p53, E2F1 and NFκB, and/or its methyltransferase activity targeting oncogenic proteins, such as BAF155, NCOA3 and PKM2 25, 31-35.